Skip to main content
Supplement ScienceSupplementScience
review587 participants

Milk Thistle (Silymarin) for Fatty Liver: What the 2017 Review Found

·

This content is for informational purposes only and does not constitute medical advice. Statements about dietary supplements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary — consult your healthcare provider before starting any supplement. Full disclaimer

The cited 2017 meta-analysis included eight trials and 587 participants, not 17 trials.

The cited 2017 meta-analysis included eight trials and 587 participants, not 17 trials. Silymarin-containing interventions lowered ALT and AST on average, but enzyme changes do not establish liver protection, reversal of fibrosis or prevention of complications. Clinical evidence remains inconsistent.

Key Findings

  • Zhong et al. included eight randomized trials and 587 participants with nonalcoholic fatty liver disease. [1]
  • Across the pooled interventions, ALT was lower by 9.16 U/L (95% CI −16.24 to −2.08) and AST by 6.57 U/L (95% CI −10.03 to −3.12) compared with control. [1]
  • The silymarin-alone subgroup had smaller estimates: ALT −5.08 U/L and AST −5.44 U/L. Results from combination interventions should not be attributed entirely to silymarin. [1]
  • Liver-enzyme changes are surrogate markers. This review does not establish that silymarin prevents liver failure, reverses fibrosis or produces the previously stated 52% steatosis response. [1]
  • NCCIH describes liver-disease results as conflicting or too limited for conclusions; two NCCIH-funded trials did not show benefit. [4]

Study Details

The therapeutic effect of silymarin in the treatment of nonalcoholic fatty disease: A meta-analysis (PRISMA) of randomized control trials
Zhong S, Fan Y, Yan Q, et al. — Medicine (Baltimore) (2017)
Eight trials found pooled decreases in ALT and AST, with limitations from varied interventions and surrogate outcomes; no established protection against liver complications.
587 participantsModerate

Practical Takeaway

Do not self-treat elevated liver enzymes or suspected fatty liver with a standard milk-thistle dose. Evaluation of the cause, alcohol and medicine review, nutrition and condition-specific care matter. Different extracts and trial regimens are not interchangeable, and the evidence does not establish a routine liver-protection dose. Discuss any use with the clinician managing the liver condition. [1][4]

Summary

A review of the 2017 silymarin meta-analysis in fatty liver disease, separating changes in liver enzymes from unproven effects on fibrosis, complications and long-term liver health.

Related Supplements

Related Conditions

Product Reviews

Frequently Asked Questions

Does milk thistle actually protect the liver?

Some studies report lower liver enzymes, but that does not prove prevention of liver injury, fibrosis or failure. Current agency guidance describes liver-disease evidence as inconsistent or insufficient. It should not be relied on to offset alcohol, medicines or other causes of liver damage. [1][4]

Evidence:Study (2017)[#1]. See full reference list below.

How much milk thistle should I take for liver health?

There is no established universal dose for liver protection. Extract composition and trial regimens vary, and a dose studied in a trial is not a recommendation for treating abnormal liver tests. Review the cause of the abnormal tests and any proposed supplement with a clinician. [1][4]

Evidence:Study (2017)[#1]. See full reference list below.

Can milk thistle help with fatty liver disease (NAFLD)?

The 2017 review found improvements in liver-enzyme markers, but that is different from demonstrating reversal of liver disease. Clinical trials have not produced consistent benefits. Use condition-specific medical care and discuss supplements as an uncertain adjunct. [1][4]

Evidence:Study (2017)[#1]. See full reference list below.

How long does milk thistle take to improve liver enzymes?

The studies do not establish a dependable time to benefit for an individual. A change in ALT or AST can have several causes and does not alone show histological improvement. Follow the monitoring plan for the underlying liver condition. [1][4]

Evidence:Study (2017)[#1]. See full reference list below.

Continue Reading

References

  1. Zhong S, Fan Y, Yan Q, Fan X, Wu B, Han Y, Zhang Y, Chen Y, Zhang H, Niu J (2017). The therapeutic effect of silymarin in the treatment of nonalcoholic fatty disease: A meta-analysis (PRISMA) of randomized control trials. Medicine (Baltimore). DOI PubMed
  2. Voroneanu L, Nistor I, Dumea R, Apetrii M, Covic A (2016). Silymarin in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Journal of Diabetes Research. DOI PubMed
  3. Federico A, Dallio M, Loguercio C (2017). Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years. Molecules. DOI PubMed
  4. National Center for Complementary and Integrative Health (2026). Milk Thistle: Usefulness and Safety. NCCIH.